Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 990
interventional 703
Observational 254
Registry 33

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 280
Drug|placebo 108
Other 59
Behavioral 40
Dietary Supplement 36
Device 35
Procedure 28
Dietary Supplement|placebo 27
Biological 10
Drug|Other 10
Drug|Procedure 8
Diagnostic Test 7
Behavioral|Other 5
Behavioral|Dietary Supplement 4
Device|Procedure 4
Behavioral|Drug 3
Other|Procedure 3
Behavioral|Device 2
Behavioral|Procedure 2
Biological|Diagnostic Test 2
Biological|placebo 2
Combination Product 2
Device|Drug 2
Device|Other 2
Dietary Supplement|Drug 2
Dietary Supplement|Drug|placebo 2
Dietary Supplement|Other 2
Dietary Supplement|Other|placebo 2
Genetic 2
Behavioral|Device|Dietary Supplement 1
Behavioral|Device|Drug 1
Behavioral|Dietary Supplement|Other 1
Behavioral|Dietary Supplement|placebo 1
Behavioral|Drug|placebo 1
Biological|Drug 1
Biological|Other 1
Combination Product|Dietary Supplement|placebo 1
Device|Diagnostic Test 1
Device|Drug|Procedure 1
Other|placebo 1
placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 287
NA 38
China 26
Germany 25
Korea, Republic of 25
United Kingdom 25
Japan 15
Denmark 14
France 13
Italy 13
Canada 12
India 12
Israel 12
Iran, Islamic Republic of 11
Netherlands 11
United States|Canada 8
Brazil 7
Egypt 7
Greece 6
Mexico 6
Austria 5
Russian Federation 5
Spain 5
Sweden 5
Switzerland 5
Taiwan 5
United States|Puerto Rico 5
Hong Kong 4
Belgium 3
Czechia|Slovakia 3
Poland 3
Turkey 3
Australia 2
Belgium|Netherlands 2
Czechia|Hungary|Slovakia 2
Finland 2
Malaysia 2
Serbia 2
Singapore 2
United States|Japan 2
United States|New Zealand 2
Australia|Austria|Belgium|Canada|France|Germany|Italy|Netherlands|New Zealand|Spain|Switzerland|United Kingdom 1
Austria|Belgium|Germany 1
Austria|Germany 1
Bangladesh 1
Belgium|Czechia|Slovakia 1
Belgium|France 1
Belgium|Netherlands|United Kingdom 1
Bulgaria 1
Bulgaria|Germany|Russian Federation 1
China|United Kingdom 1
China|United States|Argentina|Australia|Belgium|Brazil|Canada|Czechia|France|Germany|Israel|Italy|Japan|Mexico|Romania|Russian Federation|Spain 1
Croatia 1
Czech Republic 1
Czech Republic|Germany 1
Czech Republic|Poland|Slovakia 1
Czech Republic|Slovakia 1
Czechia|Hungary 1
Denmark|Netherlands 1
Ecuador 1
Finland|Sweden 1
France|Germany|Poland|Russian Federation 1
Georgia|Russian Federation 1
Georgia|Ukraine|United Kingdom 1
Germany|Poland|Sweden|United Kingdom 1
Germany|Russian Federation 1
Hungary 1
Hungary|Poland 1
Hungary|Russian Federation 1
Moldova, Republic of|Romania 1
Netherlands|Spain 1
Norway 1
Pakistan 1
Poland|Portugal|Korea, Republic of|United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|China|France|Germany|Hungary|Italy|Spain|Taiwan|Thailand|United Kingdom 1
Poland|Slovakia|United Kingdom 1
Romania 1
Slovakia 1
South Africa 1
Thailand 1
United States|Australia|Austria|Belgium|Bulgaria|Canada|Denmark|Finland|France|Greece|Japan|Netherlands|Puerto Rico|Russian Federation|Spain|Sweden|United Kingdom 1
United States|Australia|Belgium|Brazil|France|Germany|Hong Kong|Italy|Poland|Puerto Rico|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|France|Poland|Spain|United Kingdom 1
United States|Australia|Canada 1
United States|Australia|Canada|France|Germany|Japan|Korea, Republic of|Poland|Spain|United Kingdom 1
United States|Australia|Canada|Israel|Poland|Taiwan 1
United States|Belgium|Bulgaria|Germany|Lithuania|Romania 1
United States|Belgium|Canada|France|Germany|Ireland|Netherlands|Spain|United Kingdom 1
United States|Belgium|Czechia|Slovakia 1
United States|Belgium|Germany|Italy|Netherlands|Singapore 1
United States|Brazil|Puerto Rico|South Africa|Thailand|Uganda 1
United States|Canada|France|Germany|Greece|Italy|Poland|Singapore|Spain|Taiwan|Turkey 1
United States|China 1
United States|France 1
United States|France|Netherlands|United Kingdom 1
United States|France|Poland|United Kingdom 1
United States|Germany|Hungary 1
United States|Germany|Spain 1
United States|Israel 1
United States|Italy 1
United States|Mexico 1
United States|Spain 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 451
2 80
3 56
4 20
5 13
6 8
7 4
8 5
9 3
10 6
11 8
12 5
13 2
14 3
16 3
17 2
18 3
19 1
20 2
23 3
25 1
28 1
29 1
30 1
31 1
32 1
34 1
37 1
38 2
41 1
43 1
44 1
52 1
67 1
74 1
91 2
103 1
110 1
121 2
122 1
140 1
158 1

Phase

Phase Study_Count
N/A 256
Phase 1 183
Phase 2 119
Phase 4 56
Phase 3 41
Phase 1/Phase 2 22
Phase 2/Phase 3 15
Early Phase 1 11

Number of Arms

Number_of_Arms Count_of_Studies
1 153
2 327
3 93
4 91
5 7
6 4
7 2
8 1
9 1
13 1
14 2
24 1
25 1
NA 19

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 9.00000 4.0 6.00000 5.00000 6.00000 8.00000 12.0000 12.000
1st Qu. 12.00000 31.0 20.00000 14.00000 38.50000 36.50000 63.0000 32.000
Median 24.00000 54.0 28.00000 32.00000 61.00000 50.00000 108.0000 62.500
Mean 38.90909 150.8 33.00552 39.57143 96.57143 72.33333 300.4103 1625.768
3rd Qu. 71.50000 110.5 38.00000 60.00000 102.50000 75.00000 217.5000 176.500
Max. 90.00000 5000.0 154.00000 96.00000 560.00000 290.00000 6086.0000 80000.000

Trial Group Type

group_type Group_Count
Experimental 1045
Active Comparator 250
Placebo Comparator 189
No Intervention 77
Other 62
NA 19
Sham Comparator 7

Intervention Model

intervention_model Study_Count
Parallel Assignment 479
Single Group Assignment 186
Crossover Assignment 18
NA 9
Sequential Assignment 8
Factorial Assignment 3

Primary Purpose

primary_purpose Study_Count
Treatment 436
Basic Science 80
Diagnostic 51
Other 38
Prevention 38
NA 25
Supportive Care 22
Health Services Research 9
Screening 3
Device Feasibility 1

Observational Studies

Studies by Country

Country Study_Count
United States 79
NA 25
China 18
Denmark 16
France 16
Korea, Republic of 11
United Kingdom 11
Canada 8
Belgium 6
Germany 5
Switzerland 5
Egypt 4
Netherlands 4
Brazil 3
Hong Kong 3
India 3
Israel 3
United States|Canada 3
Croatia 2
Iran, Islamic Republic of 2
Italy 2
Spain 2
Taiwan 2
Turkey 2
Argentina 1
Australia 1
Australia|Germany|Hong Kong|Japan|Korea, Republic of 1
Austria 1
Austria|Switzerland 1
Croatia|Denmark|France|Netherlands|Spain|United Kingdom 1
Germany|Turkey|United Kingdom 1
Greece 1
Hungary 1
India|United States|Argentina|Brazil|China|France|Greece|Italy|Peru|Philippines|Poland|Romania|Russian Federation|Singapore|Spain|Taiwan|Thailand|United Kingdom 1
Morocco 1
Netherlands|United Kingdom 1
Norway 1
Poland 1
Romania 1
Sweden 1
Switzerland|United Kingdom 1
United States|Australia|Canada|Poland|United Kingdom 1
United States|Israel 1

Sites per Study

Site_count Study_Count
1 212
2 7
3 3
4 8
5 3
6 1
7 1
8 2
9 3
11 2
12 2
13 1
14 1
15 1
21 2
25 1
26 2
36 1
86 1

Enrollment Metrics

Measure Observational
Min 1
1st Qu 50
Median 141
Mean 427103
3rd Qu 507
Max 99999999

Observation Model

observational_model Study_Count
Cohort 160
Case-Only 26
Case-Control 21
Case Control 17
Other 16
NA 12
Case-Crossover 1
Case Control, Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 165
Cross-Sectional 42
Retrospective 28
Other 11
NA 7
Cross-Sectional, Prospective 1

Registries

Studies by Country

Country Study_Count
China 7
United States 6
France 3
Canada 2
Germany 2
United Kingdom 2
Austria 1
Denmark 1
Hungary 1
Korea, Republic of 1
NA 1
Netherlands|United Kingdom 1
Portugal|Argentina|Austria|Belarus|Belgium|Bosnia and Herzegovina|Croatia|Czechia|Denmark|Estonia|Finland|France|Georgia|Germany|Greece|Hungary|Iceland|Ireland|Israel|Italy|Latvia|Lithuania|Luxembourg|Netherlands|Norway|Poland|Romania|Russian Federation|Serbia|Slovakia|Slovenia|Spain|Sweden|Switzerland|Ukraine|United Kingdom 1
Spain|United Kingdom 1
Taiwan 1
Turkey 1
Uruguay 1

Sites per Study

Site_count Study_Count
1 24
2 2
3 2
5 1
6 1
12 1
13 1
110 1

Enrollment Metrics

Measure Registries
Min 40.0
1st Qu 176.0
Median 550.0
Mean 182784.1
3rd Qu 2000.0
Max 5940299.0

Registry Model

observational_model Study_Count
Cohort 25
Case-Control 4
Case-Only 1
Case Control 1
Other 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 27
Cross-Sectional 4
Other 2

Follow-up

target_duration Study_Count
5 Years 6
1 Day 4
10 Years 3
1 Year 2
20 Years 2
3 Months 2
30 Years 2
7 Days 2
1 Month 1
12 Months 1
17 Years 1
192 Weeks 1
2 Years 1
3 Years 1
5 Days 1
6 Months 1
6 Years 1
90 Days 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04462081 Non Alcoholic Fatty Liver Disease and Coronary Heart Disease in Type 2 Diabetes Patients https://ClinicalTrials.gov/show/NCT04462081 Completed University of California, San Diego 2015-01-31
NCT04420637 Impact of the Covid-19 Pandemic on Gastrointestinal and Liver Diseases https://ClinicalTrials.gov/show/NCT04420637 Enrolling by invitation Medical University of Graz 2020-12-31
NCT03721367 Chronic Liver Disease in Urea Cycle Disorders https://ClinicalTrials.gov/show/NCT03721367 Completed Baylor College of Medicine 2020-06-01
NCT03407833 Physiologic and Functional Adaptations of Insulin Sensitive Tissues https://ClinicalTrials.gov/show/NCT03407833 Enrolling by invitation Vanderbilt University Medical Center 2028-02-29
NCT03405909 Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study https://ClinicalTrials.gov/show/NCT03405909 Recruiting University Hospital Erlangen 2020-02-29
NCT03389152 SWE Liver Stiffness as a Predictor of Progression of Chronic Liver Diseases https://ClinicalTrials.gov/show/NCT03389152 Enrolling by invitation SuperSonic Imagine 2018-11-28
NCT03366987 Nonalcoholic Fatty Liver Disease is Associated With Increased Atrial Fibrillation Risk in an Elderly Chinese Population https://ClinicalTrials.gov/show/NCT03366987 Completed Ningbo No. 1 Hospital 2018-01-18
NCT03826381 NAFLD Among Patients With Type 2 Diabetes and CKD https://ClinicalTrials.gov/show/NCT03826381 Recruiting Rigshospitalet, Denmark 2021-08-31
NCT03295812 Stratification of Chronic Alcoholic Liver Diseases (SCALE Study) https://ClinicalTrials.gov/show/NCT03295812 Recruiting Nanfang Hospital of Southern Medical University 2019-12-30
NCT03276039 Serum Pentraxin-3 in Non-alcoholic Fatty Liver Disease With or Without Hepatitis C Virus https://ClinicalTrials.gov/show/NCT03276039 Completed Ain Shams University 2016-04-15
NCT03260660 Comparison of MR Elastography Methods Without and With Compressed Sensing https://ClinicalTrials.gov/show/NCT03260660 Completed Children’s Hospital Medical Center, Cincinnati 2017-12-01
NCT03260036 Hepatic Urea Nitrogen Handling in Patients With NASH https://ClinicalTrials.gov/show/NCT03260036 Recruiting University of Aarhus 2022-08-21
NCT03254563 Copeptin and Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03254563 Recruiting University of Colorado, Denver 2020-06-30
NCT03250572 Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD Patients https://ClinicalTrials.gov/show/NCT03250572 Completed Ain Shams University 2016-07-31
NCT03246048 Long Term Follow-up of Hepatitis C Cured Patients https://ClinicalTrials.gov/show/NCT03246048 Active, not recruiting Hospital Universitari Vall d’Hebron Research Institute 2021-01-31
NCT03228290 Functional Assessment in Liver Transplantation https://ClinicalTrials.gov/show/NCT03228290 Recruiting University of California, San Francisco 2023-12-31
NCT03224949 Comparison of ALD, NASH, and Healthy Control Patients https://ClinicalTrials.gov/show/NCT03224949 Recruiting The Cleveland Clinic 2021-07-31
NCT03221127 Kuopio Ischaemic Heart Disease Risk Factor Study (Nutrition Component) https://ClinicalTrials.gov/show/NCT03221127 Active, not recruiting University of Eastern Finland 2052-12-31
NCT03209791 Ethanol Induces Skeletal Muscle Autophagy https://ClinicalTrials.gov/show/NCT03209791 Recruiting The Cleveland Clinic 2020-12-31
NCT03198104 Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRI https://ClinicalTrials.gov/show/NCT03198104 Completed Perspectum Diagnostics Ltd 2019-03-01
NCT03193151 Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation https://ClinicalTrials.gov/show/NCT03193151 Recruiting University of Alberta 2021-08-31
NCT03190538 Nonalcoholic Steatohepatitis in Chinese Children https://ClinicalTrials.gov/show/NCT03190538 Recruiting Humanity and Health Research Centre 2027-05-31
NCT03169998 Effect of Goal-directed Fluid Therapy on Postoperative Complications https://ClinicalTrials.gov/show/NCT03169998 Recruiting Seoul National University Bundang Hospital 2020-12-31
NCT03162302 Liver Fat and Iron Quantification MRI https://ClinicalTrials.gov/show/NCT03162302 Recruiting University of California, Los Angeles 2020-10-01
NCT03151473 Longitudinal Observational Study Of Chinese With NAFLD/NASH https://ClinicalTrials.gov/show/NCT03151473 Recruiting Humanity and Health Research Centre 2027-05-31
NCT03113929 Quantitative MRI for Non-invasive Assessment of Severity of Alcoholic Liver Disease (ALD) https://ClinicalTrials.gov/show/NCT03113929 Active, not recruiting The Cleveland Clinic 2020-12-01
NCT03084328 Vitamin D Replacement in Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03084328 Completed The Cleveland Clinic 2014-12-20
NCT02272504 A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers https://ClinicalTrials.gov/show/NCT02272504 Active, not recruiting Wako Life Sciences 2020-08-31
NCT03001388 Longitudinal Assessment of Transient Elastography in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03001388 Active, not recruiting National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2022-12-31
NCT02985450 A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada https://ClinicalTrials.gov/show/NCT02985450 Recruiting University of Calgary 2019-12-31
NCT02979340 MRI to Characterize and Predict CF Liver Disease in PUSH Cohort https://ClinicalTrials.gov/show/NCT02979340 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2019-12-31
NCT02965560 Exploring Biomarkers Predicting the Outcome of Acute-on-chronic Liver Failure https://ClinicalTrials.gov/show/NCT02965560 Completed First Affiliated Hospital of Zhejiang University 2017-10-10
NCT02950610 Breath Analysis Using an Electronic Nose in Non Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02950610 Completed University of Edinburgh 2017-08-31
NCT02947594 Half-life of Plasma Phytosterols in Very Low Birth Weight Preterm Infants With Parenteral Nutrition-associated Cholestasis https://ClinicalTrials.gov/show/NCT02947594 Completed Università Politecnica delle Marche 2016-08-31
NCT02947568 Genetical Background of Non-alcoholic Fatty Liver Disease (NAFLD) in Diabetes Mellitus and in Chronic Kidney Disease https://ClinicalTrials.gov/show/NCT02947568 Active, not recruiting University of Pecs 2019-12-31
NCT02917408 Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital https://ClinicalTrials.gov/show/NCT02917408 Completed West China Hospital 2017-01-31
NCT02884037 Rifaximin Modify the Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT02884037 Completed Mansoura University 2015-05-31
NCT02877602 Patient Understanding of LiverMultiScan https://ClinicalTrials.gov/show/NCT02877602 Completed Perspectum Diagnostics Ltd 2017-12-31
NCT02863757 Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02863757 Recruiting Humanity and Health Research Centre 2026-12-31
NCT02860884 Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02860884 Completed Rennes University Hospital 2015-04-30
NCT02828579 The Impact of Bariatric Surgery on Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02828579 Completed Jagiellonian University 2016-01-31
NCT02826460 Psychosocial Risks in Liver Transplant Recipients https://ClinicalTrials.gov/show/NCT02826460 Completed Icahn School of Medicine at Mount Sinai 2016-06-30
NCT02802761 Nutritional Assessment Tool in Childhood Chronic Liver Disease https://ClinicalTrials.gov/show/NCT02802761 Completed Institute of Liver and Biliary Sciences, India 2017-10-31
NCT02796469 Meta-Analysis of Drug Therapy in Patients With Severe Alcoholic Hepatitis https://ClinicalTrials.gov/show/NCT02796469 Completed University Hospital, Lille 2016-05-31
NCT02779946 Non-invasive Liver Screening for Risk Assessment for Coronary Heart Disease https://ClinicalTrials.gov/show/NCT02779946 Completed University of Leipzig 2017-03-31
NCT02758834 Half-life of Plasma Phytosterols in Preterm Infants on Parenteral Nutrition https://ClinicalTrials.gov/show/NCT02758834 Completed Università Politecnica delle Marche 2016-04-30
NCT02754037 Non-Invasive Evaluation of Liver Steatosis, Inflammation and Fibrosis https://ClinicalTrials.gov/show/NCT02754037 Completed University of California, Davis 2020-03-30
NCT02716870 Meta-analyses of the Effect of Important Food Sources of Sugars on Cardiometabolic Risk Factors https://ClinicalTrials.gov/show/NCT02716870 Active, not recruiting University of Toronto 2020-12-31
NCT02653846 Correlation of Liver and Spleen Stiffness by RT-2D-SWE and Severity of Portal Hypertension by HVPG https://ClinicalTrials.gov/show/NCT02653846 Recruiting University Hospital Dubrava 2017-06-30
NCT02650830 Seum Bile Acid Profile in Type 2 Diabetes and Association Between Bile Cid Profile and Adipokine or Oxidative Stress https://ClinicalTrials.gov/show/NCT02650830 Completed Yonsei University 2018-07-02
NCT02650115 Evaluation of the Involvement of the Intestinal Microbiota and Choline Deficiency in the Severity of Chronic Liver Disease Explored by Analyzing Collection of Biological Samples (MICRONACH) https://ClinicalTrials.gov/show/NCT02650115 Recruiting Centre Hospitalier Departemental Vendee 2021-05-31
NCT02649049 Dietary Determinants in Patients With Nonalcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT02649049 Completed National Nutrition and Food Technology Institute 2016-02-29
NCT02601820 The Patient-Reported Outcomes Project of HCV-TARGET https://ClinicalTrials.gov/show/NCT02601820 Completed University of North Carolina, Chapel Hill 2018-07-31
NCT02363309 Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT02363309 Completed National Institutes of Health Clinical Center (CC) 2018-11-29
NCT01350648 Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection https://ClinicalTrials.gov/show/NCT01350648 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00001971 Evaluation of Patients With Liver Disease https://ClinicalTrials.gov/show/NCT00001971 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT03396705 Liver Regeneration https://ClinicalTrials.gov/show/NCT03396705 Enrolling by invitation University Health Network, Toronto 2020-12-31
NCT02548130 Impact of MELD Score for 700 Consecutive Liver Transplantations https://ClinicalTrials.gov/show/NCT02548130 Completed Centre hospitalier de l’Université de Montréal (CHUM) 2014-10-31
NCT02542020 Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and Steatosis https://ClinicalTrials.gov/show/NCT02542020 Recruiting Oswaldo Cruz Foundation 2020-05-31
NCT02520609 Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02520609 Completed National Institutes of Health Clinical Center (CC) 2020-05-14
NCT02506946 NAFLD in Adolescents and Young Adults With PCOS https://ClinicalTrials.gov/show/NCT02506946 Recruiting Columbia University 2022-12-31
NCT02457637 Chinese CLIF-C Acute-on-Chronic Liver Disease and Liver Failure Study https://ClinicalTrials.gov/show/NCT02457637 Completed Shanghai Jiao Tong University School of Medicine 2016-12-31
NCT02427204 Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality https://ClinicalTrials.gov/show/NCT02427204 Completed Icahn School of Medicine at Mount Sinai 2018-01-18
NCT02422238 Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02422238 Recruiting Maastricht University Medical Center 2017-12-31
NCT02382822 Copenhagen Co-morbidity in HIV Infection Study https://ClinicalTrials.gov/show/NCT02382822 Active, not recruiting Rigshospitalet, Denmark 2025-03-31
NCT02353455 Cells of Monocytic Origin as Surrogate Markers for Individual Drug Effects and Hepatotoxicity https://ClinicalTrials.gov/show/NCT02353455 Recruiting Ludwig-Maximilians - University of Munich 2020-03-31
NCT02329821 Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection https://ClinicalTrials.gov/show/NCT02329821 Completed Samsung Medical Center 2015-05-31
NCT02322073 Inflammation and Obesity-associated Disease https://ClinicalTrials.gov/show/NCT02322073 Active, not recruiting Göteborg University 2019-12-31
NCT02311348 Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver Biopsy https://ClinicalTrials.gov/show/NCT02311348 Completed National Institutes of Health Clinical Center (CC) 2016-12-21
NCT02285218 Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD https://ClinicalTrials.gov/show/NCT02285218 Recruiting Yonsei University 2019-03-31
NCT02267148 Utilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver Progression https://ClinicalTrials.gov/show/NCT02267148 Completed UNC Nutrition Research Institute 2014-12-31
NCT02176811 Plasma Betatrophin Levels in Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02176811 Completed Gulhane School of Medicine 2013-06-30
NCT02174367 An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis https://ClinicalTrials.gov/show/NCT02174367 Active, not recruiting King’s College London 2017-07-31
NCT02173080 Development and Assessment of The Polycystic Liver Disease Questionnaire (PLD-Q). https://ClinicalTrials.gov/show/NCT02173080 Recruiting Mayo Clinic 2020-06-30
NCT02164292 ALPPS: Safety, Feasibility and Efficacy at a Single Center https://ClinicalTrials.gov/show/NCT02164292 Completed Hospital Italiano de Buenos Aires 2014-04-30
NCT02148471 Fatty Acids, Genes and Microbiota in Fatty Liver https://ClinicalTrials.gov/show/NCT02148471 Completed University Health Network, Toronto 2015-08-31
NCT02132780 Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT02132780 Completed Virginia Commonwealth University 2016-05-31
NCT02131623 Validation of the Itch Reported Outcome (ItchRO) Diaries in Pediatric Cholestatic Liver Disease https://ClinicalTrials.gov/show/NCT02131623 Completed Mirum Pharmaceuticals, Inc. 2015-03-31
NCT02118545 Von Willebrand Factor to Predict Postoperative Outcome https://ClinicalTrials.gov/show/NCT02118545 Completed Medical University of Vienna 2016-02-29
NCT02087371 Prognosis Factors of Cardiac Complications After Liver Transplantation https://ClinicalTrials.gov/show/NCT02087371 Completed Assistance Publique - Hôpitaux de Paris 2017-04-30
NCT02084160 Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation https://ClinicalTrials.gov/show/NCT02084160 Completed Exalenz Bioscience LTD. 2018-10-31
NCT02073435 A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation https://ClinicalTrials.gov/show/NCT02073435 Completed Northwestern University 2015-05-31
NCT02070315 Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM https://ClinicalTrials.gov/show/NCT02070315 Active, not recruiting Baylor Research Institute 2020-11-30
NCT02060565 Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease https://ClinicalTrials.gov/show/NCT02060565 Recruiting Association HGE CHU Bordeaux Sud 2023-01-31
NCT01316679 An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423 https://ClinicalTrials.gov/show/NCT01316679 Completed Vanderbilt University Medical Center 2013-01-31
NCT01283230 Evaluation of Liver Fibrosis Staging With Acoustic Radiation Force Impulse Elastography https://ClinicalTrials.gov/show/NCT01283230 Completed Yonsei University 2011-04-30
NCT02044523 Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound https://ClinicalTrials.gov/show/NCT02044523 Completed Centre hospitalier de l’Université de Montréal (CHUM) 2018-06-30
NCT01988753 Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases https://ClinicalTrials.gov/show/NCT01988753 Completed Baylor College of Medicine 2016-06-30
NCT01966627 Genetics of Fatty Liver Disease in Children https://ClinicalTrials.gov/show/NCT01966627 Completed Yale University 2017-07-31
NCT01958411 Correlation Between NAFLD, Epicardial Adipose Tissue and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG) https://ClinicalTrials.gov/show/NCT01958411 Completed Korea University 2011-03-31
NCT01950429 Evaluation of Sickle Cell Liver Disease https://ClinicalTrials.gov/show/NCT01950429 Completed National Institutes of Health Clinical Center (CC) 2019-06-11
NCT01944878 The Association With Peptic Ulcer Disease and Hepatic Vein Pressure Gradient https://ClinicalTrials.gov/show/NCT01944878 Completed Chuncheon Sacred Heart Hospital 2013-08-31
NCT01932918 Antinociceptive Modalities on Ischemia Reperfusion Injury https://ClinicalTrials.gov/show/NCT01932918 Completed National Taiwan University Hospital 2015-07-31
NCT04446156 Liver Diseases in PLWH https://ClinicalTrials.gov/show/NCT04446156 Recruiting First Affiliated Hospital of Zhejiang University 2020-08-31
NCT01890460 Evaluation of Liver Disease With Elastography Measurements in Patients Undergoing Liver Transplant Surgery https://ClinicalTrials.gov/show/NCT01890460 Completed Baylor Research Institute 2015-07-31
NCT01867385 The Physiology of Fatigue in Patients With Chronic Liver Disease https://ClinicalTrials.gov/show/NCT01867385 Completed National Institutes of Health Clinical Center (CC) 2015-09-11
NCT01856465 Intestinal Microbiota and NAFLD Pre and Post Bariatric Surgery https://ClinicalTrials.gov/show/NCT01856465 Recruiting University Health Network, Toronto 2020-05-31
NCT01828528 Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01828528 Completed Sheba Medical Center 2016-08-31
NCT01825213 Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT https://ClinicalTrials.gov/show/NCT01825213 Completed Massachusetts General Hospital 2016-10-31
NCT01812226 Alcohol Biomarkers in Post-Liver Transplant Patients https://ClinicalTrials.gov/show/NCT01812226 Completed Northwestern University 2015-10-31
NCT01761851 Resting Energy Expenditure in Patients on the Waiting List for Liver Transplantation https://ClinicalTrials.gov/show/NCT01761851 Completed Federal University of Minas Gerais 2011-06-30
NCT01705522 Multimodal Approach in IBD Patients https://ClinicalTrials.gov/show/NCT01705522 Recruiting Clinical Hospital Colentina 2019-09-30
NCT01701687 Biomarkers for the Prognosis of Decompensated Alcoholic Liver Disease https://ClinicalTrials.gov/show/NCT01701687 Completed University of Nottingham 2015-07-31
NCT01674972 Glucose-induced Glucagon-like Peptide 1 (GLP-1) Secretion in NAFLD Patients Compared to Healthy Controls https://ClinicalTrials.gov/show/NCT01674972 Completed University Hospital, Basel, Switzerland 2012-04-30
NCT01657773 Study of the Association of Nonalcoholic Fatty Liver Disease With Colorectal Malignant Neoplasm https://ClinicalTrials.gov/show/NCT01657773 Completed Wenzhou Medical University 2012-06-30
NCT01629095 Genetic Studies of Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01629095 Completed National Institutes of Health Clinical Center (CC) NA
NCT01619475 Adult-to-Adult Living Donor Transplant Cohort Study https://ClinicalTrials.gov/show/NCT01619475 Completed Arbor Research Collaborative for Health 2014-08-31
NCT03967067 Risk Factors for Major Complications After Liver Resection https://ClinicalTrials.gov/show/NCT03967067 Completed Moroccan Society of Surgery 2016-03-31
NCT01524562 HIV Accelerated Liver Disease in Uganda https://ClinicalTrials.gov/show/NCT01524562 Completed National Institutes of Health Clinical Center (CC) 2015-05-12
NCT01492283 Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without Diabetes https://ClinicalTrials.gov/show/NCT01492283 Completed University Hospital, Gentofte, Copenhagen 2013-05-31
NCT01490203 Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT01490203 Completed Seoul National University Hospital 2014-02-28
NCT01477307 Dietary Intervention and Intestinal Microbiota in Non-alcoholic Fatty Liver https://ClinicalTrials.gov/show/NCT01477307 Completed University Hospital, Geneva 2016-08-31
NCT01458756 Study of Psychological Defense Mechanisms Used by Liver Transplant Patients https://ClinicalTrials.gov/show/NCT01458756 Completed University Hospital, Lille 2016-10-31
NCT01390766 Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation) https://ClinicalTrials.gov/show/NCT01390766 Completed GlaxoSmithKline 2011-05-31
NCT01390194 A Rapid 10-minute Liver MRI https://ClinicalTrials.gov/show/NCT01390194 Completed University of Nebraska 2015-06-30
NCT01381432 Special Drug Use Investigation for IMURAN (Azathioprine) Tablet (Pulmones Transplantation) https://ClinicalTrials.gov/show/NCT01381432 Completed GlaxoSmithKline 2011-05-31
NCT01354405 Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE) https://ClinicalTrials.gov/show/NCT01354405 Completed Radboud University 2014-06-30
NCT01324414 Impact of Muscle Insulin Resistance on the Pathogenesis of Non Alcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT01324414 Completed Mayo Clinic 2016-01-31
NCT04439084 COVID-19 in Patients With Chronic Liver Diseases https://ClinicalTrials.gov/show/NCT04439084 Enrolling by invitation Stanford University 2021-06-30
NCT04384159 Combination Diagnostic Strategies in NAFLD https://ClinicalTrials.gov/show/NCT04384159 Completed University Hospital, Montpellier 2019-07-01
NCT04380493 The Use of the Transient Elastography Paediatric Probe, Compared to the M Probe, Indirect Biomarkers and Histology https://ClinicalTrials.gov/show/NCT04380493 Completed Hospital Vall d’Hebron 2019-12-31
NCT04375670 COVID19-FOIE National Observatory https://ClinicalTrials.gov/show/NCT04375670 Recruiting Assistance Publique - Hôpitaux de Paris 2020-12-31
NCT04371042 PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies https://ClinicalTrials.gov/show/NCT04371042 Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS 2035-12-31
NCT04367012 Fatty Liver Among Employees at Banha University https://ClinicalTrials.gov/show/NCT04367012 Completed Benha University 2019-02-20
NCT04366999 Bariatric Surgery Effect Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT04366999 Recruiting Beijing Friendship Hospital 2023-04-20
NCT04352491 An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease https://ClinicalTrials.gov/show/NCT04352491 Completed Institute of Liver and Biliary Sciences, India 2020-05-31
NCT04341012 Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases https://ClinicalTrials.gov/show/NCT04341012 Recruiting Mayo Clinic 2021-12-31
NCT04340817 Fatty Liver Disease in Nordic Countries https://ClinicalTrials.gov/show/NCT04340817 Recruiting Copenhagen University Hospital, Hvidovre 2025-09-01
NCT04339725 Gut Microbiota Metagenomics for Chronic Liver Disease https://ClinicalTrials.gov/show/NCT04339725 Active, not recruiting Chuncheon Sacred Heart Hospital 2020-03-01
NCT04307264 CHESS Criteria for Varices Screening in Compensated Advanced Chronic Liver Disease (CHESS2001/APPHA2001) https://ClinicalTrials.gov/show/NCT04307264 Recruiting Hepatopancreatobiliary Surgery Institute of Gansu Province 2021-03-17
NCT04234139 Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver Transplantation https://ClinicalTrials.gov/show/NCT04234139 Enrolling by invitation Johns Hopkins University 2025-12-31
NCT04227782 MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH) https://ClinicalTrials.gov/show/NCT04227782 Recruiting University of Oxford 2021-09-01
NCT04220723 Evaluation of Frailty and Functional Capacity in End-Stage Liver Disease https://ClinicalTrials.gov/show/NCT04220723 Enrolling by invitation Hacettepe University 2020-04-20
NCT04191018 GastrOesophageal Varices After Sustained Virological Response https://ClinicalTrials.gov/show/NCT04191018 Recruiting Oswaldo Cruz Foundation 2022-08-14
NCT04141592 Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT04141592 Recruiting Queen Mary University of London 2020-09-05
NCT04132440 Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT04132440 Recruiting M.D. Anderson Cancer Center 2020-12-31
NCT04116242 MERTK Signalling in Monocytes/Macrophages in Patients With Liver Disease https://ClinicalTrials.gov/show/NCT04116242 Recruiting University Hospital, Basel, Switzerland 2020-08-31
NCT04111692 A Prospective Observational Study of Foam Sclerotherapy . https://ClinicalTrials.gov/show/NCT04111692 Recruiting Mayo Clinic 2020-12-10
NCT04076605 Bleeding in Hospitalized Patients With Liver Disease Undergoing Invasive Procedures https://ClinicalTrials.gov/show/NCT04076605 Recruiting University of Virginia 2020-11-01
NCT04066608 Prevalence of Advanced Fibrosis in Patients Living With HIV https://ClinicalTrials.gov/show/NCT04066608 Enrolling by invitation Johannes Gutenberg University Mainz 2020-10-01
NCT04066153 Patient Reported Unmet Needs for Function and Supportive Occupational- and Physiotherapy Rehabilitation Interventions https://ClinicalTrials.gov/show/NCT04066153 Completed Rigshospitalet, Denmark 2019-11-08
NCT04059029 Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients https://ClinicalTrials.gov/show/NCT04059029 Enrolling by invitation Taipei Medical University Hospital 2020-07-31
NCT04058327 A Study of MHE in Patients With Liver Diseases https://ClinicalTrials.gov/show/NCT04058327 Recruiting Tongji Hospital 2020-06-30
NCT04055870 Efficacy, Safety, and Adequacy of EUS-guided Liver Biopsy https://ClinicalTrials.gov/show/NCT04055870 Enrolling by invitation Methodist Health System 2022-08-31
NCT04043585 Bariatric Surgery on NASH https://ClinicalTrials.gov/show/NCT04043585 Recruiting University Hospital, Gentofte, Copenhagen 2021-05-01
NCT04037995 Real World Study of End-stage Liver Disease in China https://ClinicalTrials.gov/show/NCT04037995 Recruiting Huashan Hospital 2020-09-01
NCT04028869 Clinical Observation of Long-term Efficacy and Safety of Glycyrrhizic Acid Preparation in the Therapy of Autoimmune Liver Disease https://ClinicalTrials.gov/show/NCT04028869 Completed Beijing Ditan Hospital 2019-03-30
NCT04022681 Long-term Follow Up of Patients in the Birmingham and Lambeth Liver Evaluation Strategies (BALLETS) Study https://ClinicalTrials.gov/show/NCT04022681 Completed University of Warwick 2010-05-01
NCT04004481 Metabolites of Tramadol in the Postoperative Surgical Patients https://ClinicalTrials.gov/show/NCT04004481 Completed Osijek University Hospital 2020-02-28
NCT03995537 Monocytic Expression of HLA-DR After Liver Transplantation https://ClinicalTrials.gov/show/NCT03995537 Recruiting Hospices Civils de Lyon 2021-09-26
NCT03986684 Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03986684 Completed Hippocration General Hospital 2017-05-30
NCT03961516 Glycemic Characterization and Pancreatic Imaging Correlates in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03961516 Recruiting University Hospitals Cleveland Medical Center 2020-07-01
NCT03960710 Automatic Segmentation of Polycystic Liver https://ClinicalTrials.gov/show/NCT03960710 Recruiting Hospices Civils de Lyon 2019-07-31
NCT03866421 NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney Transplantation https://ClinicalTrials.gov/show/NCT03866421 Recruiting Rigshospitalet, Denmark 2021-08-31
NCT03864744 Hepatic Histology and Metabolism Following Total Pancreatectomy and Pancreaticoduodenectomy https://ClinicalTrials.gov/show/NCT03864744 Enrolling by invitation Steno Diabetes Center Copenhagen 2020-08-30
NCT03847116 Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03847116 Completed Ningbo No. 1 Hospital 2019-01-01
NCT03834285 Liver Disease in Pregnancy https://ClinicalTrials.gov/show/NCT03834285 Recruiting King’s College Hospital NHS Trust 2024-04-08
NCT03833297 Monitoring the HePAtological TOXicity of Drugs (HePATOX) https://ClinicalTrials.gov/show/NCT03833297 Recruiting Groupe Hospitalier Pitie-Salpetriere 2020-02-04
NCT03813862 Observational Pharmaco‐Epidemiology Research & Analysis https://ClinicalTrials.gov/show/NCT03813862 Recruiting Epividian 2027-11-30
NCT03809559 Repeatability and Reproducibility of Quantitative MRCP https://ClinicalTrials.gov/show/NCT03809559 Completed Perspectum Diagnostics Ltd 2018-09-08
NCT03789825 Population-based Study in Screening for Liver Fibrosis https://ClinicalTrials.gov/show/NCT03789825 Enrolling by invitation Fundacion Clinic per a la Recerca Biomédica 2020-12-31
NCT03787108 Measuring Fatty Liver With Ultrasound and MRS in Children With Overweight or Obesity https://ClinicalTrials.gov/show/NCT03787108 Recruiting Maastricht University Medical Center 2019-12-31
NCT03776760 Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination https://ClinicalTrials.gov/show/NCT03776760 Recruiting Kirby Institute 2022-02-28
NCT03766633 Accuracy of the LiverVision® Semi-automated Liver Volumetry Software https://ClinicalTrials.gov/show/NCT03766633 Recruiting Royal Free Hospital NHS Foundation Trust 2020-03-31
NCT03754452 Evaluation of the Sarcopenia in Hepatobiliary Surgery https://ClinicalTrials.gov/show/NCT03754452 Recruiting University Hospital, Angers 2020-01-01
NCT03748511 Identification of Microbial Properties Predicting a Worsening Course of Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03748511 Active, not recruiting HaEmek Medical Center, Israel 2020-04-01
NCT03743272 Repeatability and Reproducibility of Multiparametric MRI https://ClinicalTrials.gov/show/NCT03743272 Recruiting Perspectum Diagnostics Ltd 2020-05-17
NCT03723317 Associated Balance of Risk Score - Comprehensive Complication Index for the Prediction of Post-transplant Survival https://ClinicalTrials.gov/show/NCT03723317 Completed European Hepatocellular Cancer Liver Transplant Group 2018-10-15
NCT03717792 Vascular Liver Disease Evaluation, Follow Up and Non-Invasive Diagnostics Program https://ClinicalTrials.gov/show/NCT03717792 Recruiting University Hospital, Bonn 2025-12-31
NCT03692897 An Observational Study of Patients Undergoing Therapy for Chronic Hepatitis B (HBV) Infection https://ClinicalTrials.gov/show/NCT03692897 Active, not recruiting Target PharmaSolutions, Inc. 2023-01-31
NCT03683589 De Novo Lipogenesis in Severity of NAFLD https://ClinicalTrials.gov/show/NCT03683589 Active, not recruiting University of Missouri-Columbia 2019-08-21
NCT03678727 Hepatic Metabolic Flexibility in Obese With NAFL and NASH https://ClinicalTrials.gov/show/NCT03678727 Recruiting University of Aarhus 2020-11-01
NCT03663062 ObeSity Related Colorectal Adenoma Risk https://ClinicalTrials.gov/show/NCT03663062 Recruiting South Tyneside and Sunderland NHS Foundation Trust 2019-07-01
NCT03641872 A Validation Cohort for ACLF Diagnosis and Prognosis https://ClinicalTrials.gov/show/NCT03641872 Active, not recruiting Shanghai Jiao Tong University School of Medicine 2020-04-21
NCT03635541 Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03635541 Recruiting Beijing Friendship Hospital 2021-02-28
NCT03632148 Effect of Liver MSCs in Blood of Patients With Liver Disease. https://ClinicalTrials.gov/show/NCT03632148 Completed Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2018-12-01
NCT03609411 Splenectomy During Whole Liver Transplantation https://ClinicalTrials.gov/show/NCT03609411 Completed Hospices Civils de Lyon 2017-01-31
NCT03608748 Early Detection of Advanced Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03608748 Recruiting HaEmek Medical Center, Israel 2020-08-01
NCT03587298 Use of Shear Wave Elastography to Assess Non-alcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT03587298 Recruiting RWTH Aachen University 2019-07-31
NCT03572465 Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis https://ClinicalTrials.gov/show/NCT03572465 Recruiting Centre hospitalier de l’Université de Montréal (CHUM) 2024-10-30
NCT03563404 Portal Blood Flushes in the Peri-Reperfusion Stage of Liver Transplantation https://ClinicalTrials.gov/show/NCT03563404 Completed Medical University of South Carolina 2016-06-29
NCT03562585 Immunological Measurement of Aspartate/Alanine Aminotransferase https://ClinicalTrials.gov/show/NCT03562585 Completed Chuncheon Sacred Heart Hospital 2010-12-30
NCT03534908 Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: the Correlation Analysis and Risk Prediction Model Study https://ClinicalTrials.gov/show/NCT03534908 Active, not recruiting Wuhan University 2020-09-30
NCT03525769 Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes https://ClinicalTrials.gov/show/NCT03525769 Recruiting Nanfang Hospital of Southern Medical University 2025-12-31
NCT03509194 Better Diagnostic Tools for Children and Adolescents With Acute Liver Failure and Chronic Liver Insufficiency https://ClinicalTrials.gov/show/NCT03509194 Recruiting Rigshospitalet, Denmark 2020-12-17
NCT03508388 Value on Survival of Liver Volume After an Acute Decompensation of an Alcoholic Cirrhosis https://ClinicalTrials.gov/show/NCT03508388 Recruiting University Hospital, Montpellier 2020-12-31
NCT03483272 MRI to Assess the Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome (HRS-AKI) https://ClinicalTrials.gov/show/NCT03483272 Recruiting Hvidovre University Hospital 2023-01-31
NCT03443934 Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive Assessment https://ClinicalTrials.gov/show/NCT03443934 Recruiting Hvidovre University Hospital 2023-04-30
NCT03442361 Olive Oil and Soybean 1 Oil Based Intravenous Lipid Emulsions, Liver Chemistry and Clinical Outcomes https://ClinicalTrials.gov/show/NCT03442361 Completed University of Calgary 2015-06-30
NCT03440164 Superior Silybin Bioavailability in Healthy Volunteers https://ClinicalTrials.gov/show/NCT03440164 Completed Medica Sur Clinic & Foundation 2016-12-08
NCT03438916 MRI to Assess the Effect of Non-selective Beta-blocker in Patients With Cirrhosis https://ClinicalTrials.gov/show/NCT03438916 Recruiting Hvidovre University Hospital 2023-04-30
NCT03434639 Fluorescence Spectroscopy for Gut Permeability Assessment https://ClinicalTrials.gov/show/NCT03434639 Recruiting Imperial College London 2021-09-30
NCT01257685 Selenoprotein P and Non-alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT01257685 Completed Korea University 2008-08-31
NCT01241227 Prognosis Value of Transient Elastography and Non-invasive Markers of Fibrosis in Patients With Chronic Liver Disease https://ClinicalTrials.gov/show/NCT01241227 Completed Association HGE CHU Bordeaux Sud NA
NCT01237574 Multicentre Prospective Cohort Study of Patients With Chronic Alcoholic and/or Metabolic Liver Disease https://ClinicalTrials.gov/show/NCT01237574 Active, not recruiting University Hospital, Bordeaux 2020-11-01
NCT01202253 Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom https://ClinicalTrials.gov/show/NCT01202253 Completed Pfizer 2011-05-31
NCT01200082 Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases https://ClinicalTrials.gov/show/NCT01200082 Recruiting University of Nebraska 2021-12-31
NCT01163240 Epidemiological Study in Children and Adolescents With Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT01163240 Completed Novartis 2011-09-30
NCT01128010 Role of CCL2 in Alcoholic Liver Diseases https://ClinicalTrials.gov/show/NCT01128010 Completed Erasme University Hospital NA
NCT01122797 Influence of Adiponutrin in Chronic Liver Disease https://ClinicalTrials.gov/show/NCT01122797 Completed Erasme University Hospital 2010-01-31
NCT01110577 Study of Magnetic Resonance Imaging (MRI) to Quantify Liver Fat in Diabetic and Pre-Diabetic Patients (0000-171) https://ClinicalTrials.gov/show/NCT01110577 Completed Merck Sharp & Dohme Corp. 2010-07-31
NCT01100398 Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver Biopsy https://ClinicalTrials.gov/show/NCT01100398 Completed Brooke Army Medical Center 2010-05-31
NCT01081210 Screening of Patients Admitted to a Local Hospital With Pocket-sized Ultrasound https://ClinicalTrials.gov/show/NCT01081210 Completed Levanger Hospital 2010-09-30
NCT01061684 NAFLD Pediatric Database 2 https://ClinicalTrials.gov/show/NCT01061684 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2020-05-31
NCT01034865 Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer https://ClinicalTrials.gov/show/NCT01034865 Completed Stanford University 2009-06-30
NCT01030484 Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2 https://ClinicalTrials.gov/show/NCT01030484 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2020-05-31
NCT01007955 Assessment of Insulin Resistance, NAFLD, Predictors of CV Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass Surgery https://ClinicalTrials.gov/show/NCT01007955 Completed University of Massachusetts, Worcester 2012-05-31
NCT01002261 Hepatic Metabolism of Galactose and the Galactose Analog FDGal in Patients With Liver Disease and Healthy Subjects https://ClinicalTrials.gov/show/NCT01002261 Completed Aarhus University Hospital 2015-01-31
NCT00983463 Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT00983463 Enrolling by invitation Vanderbilt University Medical Center 2024-11-30
NCT00940537 Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD) https://ClinicalTrials.gov/show/NCT00940537 Completed Washington University School of Medicine 2010-03-31
NCT00930384 A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis https://ClinicalTrials.gov/show/NCT00930384 Completed George Washington University 2016-04-30
NCT03870568 Functional Assessment in Liver Transplantation https://ClinicalTrials.gov/show/NCT03870568 Recruiting Baylor Research Institute 2020-12-31
NCT00889577 Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons https://ClinicalTrials.gov/show/NCT00889577 Completed Uniformed Services University of the Health Sciences 2010-03-31
NCT00887887 The Association Between Gene Polymorphisms and Infectious Complications After Liver Surgery https://ClinicalTrials.gov/show/NCT00887887 Completed Maastricht University Medical Center 2010-06-30
NCT00883454 Estimation of Functional Liver Reserve Using Cholinesterases https://ClinicalTrials.gov/show/NCT00883454 Completed University of Milan NA
NCT00839709 Peripheral Immunologic Response of Solid Organ Transplant Recipients to Depletion Versus Non-depletion Protocols https://ClinicalTrials.gov/show/NCT00839709 Completed University of Washington 2010-09-30
NCT03915002 Integrated Approaches for Identifying Molecular Targets in Liver Disease https://ClinicalTrials.gov/show/NCT03915002 Recruiting University of Pittsburgh 2022-04-15
NCT03914196 Fontan Associated Liver Disease https://ClinicalTrials.gov/show/NCT03914196 Recruiting Children’s Hospital Medical Center, Cincinnati 2027-12-31
NCT01658982 Cardiopulmonary Exercise Testing in Cirrhotic Patients: a Pilot Study https://ClinicalTrials.gov/show/NCT01658982 Completed Mayo Clinic 2013-06-30
NCT00823277 Metabolic Syndrome and Gen-polymorphs Influence on Weightloss Among Children in Treatment for Overweight https://ClinicalTrials.gov/show/NCT00823277 Completed Zealand University Hospital 2012-08-31
NCT03456518 Pattern of Acute on Chronic Liver Failure in Patient With HCV Related Chronic Liver Disease https://ClinicalTrials.gov/show/NCT03456518 Completed Assiut University 2019-10-31
NCT01467011 Myfortic, Prograf, and Corticosteroids in de Novo Liver Transplantation https://ClinicalTrials.gov/show/NCT01467011 Completed The Methodist Hospital System 2013-12-31
NCT01900808 Improvement of Transient Elastography Applicability and Diagnostic Accuracy to Identify Significant Fibrosis by Experienced Operators Using the M and XL Probe. https://ClinicalTrials.gov/show/NCT01900808 Completed Parc de Salut Mar 2012-04-30
NCT00804583 Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease https://ClinicalTrials.gov/show/NCT00804583 Active, not recruiting University of North Carolina, Chapel Hill 2021-07-31
NCT03155984 Optimizing HBV Management During Anti-CD20 Antibodies https://ClinicalTrials.gov/show/NCT03155984 Completed The University of Hong Kong 2017-06-01
NCT02579408 Quantifying Steatosis in Liver Transplant Donors https://ClinicalTrials.gov/show/NCT02579408 Recruiting The University of Hong Kong 2021-09-30
NCT03245606 Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver Disease https://ClinicalTrials.gov/show/NCT03245606 Active, not recruiting Rennes University Hospital 2020-07-07
NCT03178630 MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease https://ClinicalTrials.gov/show/NCT03178630 Recruiting Children’s Hospital Medical Center, Cincinnati 2030-02-28
NCT03175471 MRI Based Biomarkers in Pediatric Autoimmune Liver Disease https://ClinicalTrials.gov/show/NCT03175471 Recruiting Children’s Hospital Medical Center, Cincinnati 2021-01-30
NCT02306018 Evaluation of EV1000â„¢/volumeViewâ„¢ for Cardiac Output Monitoring in Liver Transplantation https://ClinicalTrials.gov/show/NCT02306018 Completed Samsung Medical Center 2015-09-30
NCT04165343 Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORER https://ClinicalTrials.gov/show/NCT04165343 Recruiting University of California, Davis 2022-12-31
NCT04103840 Invasive Fungal Infections in Severe Alcohol-associated Hepatitis https://ClinicalTrials.gov/show/NCT04103840 Recruiting Postgraduate Institute of Medical Education and Research 2022-10-01
NCT03898414 Patterns and Outcome of Autoimmune Related Liver Disease https://ClinicalTrials.gov/show/NCT03898414 Recruiting Assiut University 2021-04-01
NCT00953693 Patient Specific Induced Pluripotency Stem Cells (PSiPS) https://ClinicalTrials.gov/show/NCT00953693 Completed Royan Institute 2010-01-31
NCT03800069 Validation of Point of Care Liver Function Tests https://ClinicalTrials.gov/show/NCT03800069 Active, not recruiting University of Pennsylvania 2019-10-02
NCT00770198 sgp130 in Chronic Human Liver Disease https://ClinicalTrials.gov/show/NCT00770198 Completed Erasme University Hospital 2007-01-31
NCT00708617 FIBROSCAN Validation and Interest of Fibrotest - FIBROSCAN Association for Fibrosis Diagnosis in Alcoholic Liver Disease https://ClinicalTrials.gov/show/NCT00708617 Completed Assistance Publique - Hôpitaux de Paris 2013-07-31
NCT00681499 Quality of Life After Liver Resection https://ClinicalTrials.gov/show/NCT00681499 Completed University of Bern 2014-01-31
NCT00679692 Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease https://ClinicalTrials.gov/show/NCT00679692 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2008-03-31
NCT00677625 Pediatric Liver Database https://ClinicalTrials.gov/show/NCT00677625 Completed Medical College of Wisconsin 2016-09-15
NCT00610597 Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease https://ClinicalTrials.gov/show/NCT00610597 Completed Erasme University Hospital 2007-01-31
NCT00575133 Prospective Cohort Study in Patients With NAFLD https://ClinicalTrials.gov/show/NCT00575133 Recruiting University of Zurich NA
NCT00547924 Transoesophageal Echocardiography in Liver Transplantation https://ClinicalTrials.gov/show/NCT00547924 Completed University of Zurich 2010-01-31
NCT00488917 Sepsis, Endothelial Function, and Lipids in Critically Ill Patients With Liver Failure (the SELLIFA Study) https://ClinicalTrials.gov/show/NCT00488917 Completed Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2009-08-31
NCT00382668 A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug https://ClinicalTrials.gov/show/NCT00382668 Completed Bristol-Myers Squibb 2007-08-31
NCT00345930 DILIN’s Prospective Study https://ClinicalTrials.gov/show/NCT00345930 Recruiting Duke University 2023-06-30
NCT00238693 Transplant Patient Registry of Liver, Kidney and/or Pancreas https://ClinicalTrials.gov/show/NCT00238693 Completed Virginia Commonwealth University 2018-08-27
NCT00074386 Kidney and Liver Transplantation in People With HIV https://ClinicalTrials.gov/show/NCT00074386 Completed University of California, San Francisco 2013-08-31
NCT00011284 Mechanisms of Inflammatory Liver Injury https://ClinicalTrials.gov/show/NCT00011284 Completed National Institute of Environmental Health Sciences (NIEHS) NA
NCT00005306 Natural History of Post-transfusion Non-A, Non-B Hepatitis https://ClinicalTrials.gov/show/NCT00005306 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005305 Hepatitis Delta Infections in Hemophiliacs https://ClinicalTrials.gov/show/NCT00005305 Completed University of North Carolina, Chapel Hill 1991-09-30
NCT00005304 Delta Hepatitis and Liver Disease in Hemophiliacs https://ClinicalTrials.gov/show/NCT00005304 Completed Baylor College of Medicine NA
NCT00005657 Genetics of Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT00005657 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001719 Magnetic Resonance Imaging of Blood Flow in the Liver and Abdomen https://ClinicalTrials.gov/show/NCT00001719 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03060694 Screening Diabetes Patients for NAFLD With Controlled Attenuation Parameter and Liver Stiffness Measurements https://ClinicalTrials.gov/show/NCT03060694 Completed Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2017-02-28
NCT03025074 Blood Collection Biorepository for Liver Disease Research https://ClinicalTrials.gov/show/NCT03025074 Recruiting State University of New York at Buffalo 2099-12-31
NCT02908048 Extracellular RNA Markers of Liver Disease and Cancer https://ClinicalTrials.gov/show/NCT02908048 Active, not recruiting Mayo Clinic 2021-07-31
NCT02897908 Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database https://ClinicalTrials.gov/show/NCT02897908 Recruiting State University of New York at Buffalo 2026-12-31
NCT02699736 EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV https://ClinicalTrials.gov/show/NCT02699736 Enrolling by invitation Rigshospitalet, Denmark 2030-12-31
NCT02663388 Epigenetic Mechanisms and Severe Obesity (Biological Tissue Collection) https://ClinicalTrials.gov/show/NCT02663388 Recruiting University of Lorraine 2026-01-31
NCT02037867 Nottingham Community Liver Biomarkers Cohort https://ClinicalTrials.gov/show/NCT02037867 Recruiting University of Nottingham 2033-05-31
NCT02391168 Fatty Liver Disease Collaborative Research in China https://ClinicalTrials.gov/show/NCT02391168 Recruiting Fatty Liver and Alcoholic Liver Disease Study Group, China 2020-12-31
NCT02390232 Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASH https://ClinicalTrials.gov/show/NCT02390232 Completed University Hospital, Toulouse 2017-11-30
NCT02337673 Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography https://ClinicalTrials.gov/show/NCT02337673 Completed Johannes Gutenberg University Mainz 2016-03-31
NCT02298439 Fatty Liver Patient Registry https://ClinicalTrials.gov/show/NCT02298439 Recruiting University Health Network, Toronto 2021-01-31
NCT01988441 The Influence of Autophagy on Fatty Liver https://ClinicalTrials.gov/show/NCT01988441 Recruiting Far Eastern Memorial Hospital 2021-08-31
NCT01760356 Study of PD/PK/PG Relationships of Tacrolimus and Cyclosporin in Liver Transplant Patients https://ClinicalTrials.gov/show/NCT01760356 Active, not recruiting UDA Centro Nacional Hepato-Bilio-Pancreático 2015-02-28
NCT04422223 Prospective Cohort Study of Disease and Outcomes in Cirrhosis https://ClinicalTrials.gov/show/NCT04422223 Recruiting Copenhagen University Hospital, Hvidovre 2024-12-30
NCT04277819 The Use of Novel Diagnostic Tools to Increase Detection of Early Fibrosis in Cystic Fibrosis Related Liver Disease to Improve Clinical Management https://ClinicalTrials.gov/show/NCT04277819 Recruiting Manchester University NHS Foundation Trust 2020-08-30
NCT04255082 Mindfulness and Shared Decision Making https://ClinicalTrials.gov/show/NCT04255082 Recruiting Methodist Health System 2020-12-31
NCT04213183 Association of Eye With Hepatobiliary Disorders :Qualitative Analysis Via Deep Learning https://ClinicalTrials.gov/show/NCT04213183 Recruiting Sun Yat-sen University 2019-12-25
NCT04190849 European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD) https://ClinicalTrials.gov/show/NCT04190849 Recruiting Cambridge University Hospitals NHS Foundation Trust 2047-11-30
NCT04106518 Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease https://ClinicalTrials.gov/show/NCT04106518 Recruiting University Hospital, Lille 2022-10-31
NCT04104282 the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease. https://ClinicalTrials.gov/show/NCT04104282 Recruiting Xijing Hospital 2020-12-27
NCT03847753 Exploring the Comorbidity Between Mental Disorders and General Medical Conditions https://ClinicalTrials.gov/show/NCT03847753 Completed University of Aarhus 2016-12-31
NCT03842748 Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis https://ClinicalTrials.gov/show/NCT03842748 Recruiting Beijing Municipal Administration of Hospitals 2021-12-30
NCT03633812 Effect of Preoperative Beta Blocker Use Postoperative Renal Function in the Patients Undergoing Liver Transplantation https://ClinicalTrials.gov/show/NCT03633812 Recruiting Asan Medical Center 2019-12-31
NCT03569826 Canadian Network for Autoimmune Liver Disease https://ClinicalTrials.gov/show/NCT03569826 Recruiting University Health Network, Toronto 2025-12-31
NCT03566173 Association Between Nonalcoholic Fatty Liver Disease and Acute Pancreatitis https://ClinicalTrials.gov/show/NCT03566173 Completed Ningbo No. 1 Hospital 2018-04-01
NCT03541057 Vienna Vascular Liver Disease Study https://ClinicalTrials.gov/show/NCT03541057 Recruiting Medical University of Vienna 2022-12-31
NCT03445585 Biobank for Cholestatic Liver Diseases. https://ClinicalTrials.gov/show/NCT03445585 Enrolling by invitation Mayo Clinic 2030-01-31
NCT03768141 International Liver Surgery Outcomes Study https://ClinicalTrials.gov/show/NCT03768141 Recruiting Royal Free Hospital NHS Foundation Trust 2020-03-31
NCT02893657 The Role and Dynamics of Liver Dysfunction in Patients Undergoing Cardiac Surgery https://ClinicalTrials.gov/show/NCT02893657 Recruiting Semmelweis University Heart and Vascular Center 2020-05-31
NCT03131427 China Registry for Genetic / Metabolic Liver Diseases https://ClinicalTrials.gov/show/NCT03131427 Recruiting Beijing Friendship Hospital 2022-04-28
NCT03267069 Evaluating Alcohol Use in Alcoholic Liver Disease https://ClinicalTrials.gov/show/NCT03267069 Recruiting New York Presbyterian Hospital 2026-11-01
NCT02929940 Liver Disease in Patients With alpha1-antitrypsin Deficiency https://ClinicalTrials.gov/show/NCT02929940 Recruiting RWTH Aachen University 2020-04-30
NCT02733549 Is The Sudden Onset of Dizziness A Symptom of Acute Liver Dysfunction? https://ClinicalTrials.gov/show/NCT02733549 Completed Adiyaman University Research Hospital 2013-03-31